search
Back to results

Oral Supplement in Older Adults to Support Physical Fitness and Mental Well-being (PQQA)

Primary Purpose

Osteo-arthritis

Status
Recruiting
Phase
Phase 1
Locations
United Kingdom
Study Type
Interventional
Intervention
Q-actin
Placebo
Sponsored by
Aberystwyth University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Osteo-arthritis focused on measuring Older adults, Mental well-being, Physical fitness, Sleep quality

Eligibility Criteria

50 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: over 50 years, mixed gender, mixed ethnicity Consenting adults >50 y Age Commit to urine sampling Able to commit to attending WARU or the remote centre for measurements of physical strength, finger dexterity, quality of life, diet choices, sleep Able to restrict from consumption of cucumber, gherkins, and melon for two days before coming to WARU or the remote centre Exclusion Criteria: Showing (or anyone within the household) any COVID-19 symptoms (see COVID-19 basic health screen)* Higher risk or vulnerable from coronavirus or live with someone at a higher risk of a severe illness from COVID-19 (over 70, undergoing cancer treatment, high risk of getting infections). Had a letter from the NHS advising you to shield (isolate) Had been at risk of exposure to COVID-19 such as travel, contact with someone with COVID-19, been exposed to the virus, or has been asked to self-isolate by the track and trace system. Serious health conditions that require daily long-term medication

Sites / Locations

  • Well-being and Health Assessment Research Unit (WARU)Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Q-actin

Placebo

Arm Description

Q-actin gummies (2 x 10mg) daily for 12 weeks

Placebo gummies (2 x 10mg) daily for 12 weeks

Outcomes

Primary Outcome Measures

Physical strength
Hand grip strength using a hand held dynamometer
Finger dexterity measurements
Nine-Hole Peg Test (9HPT)

Secondary Outcome Measures

EuroQol 5 Dimension 5L (combined score)
EuroQol 5 Dimension 5 5L questionnaire: Generic quality of life. Mobility- Level 1-5 Self-Care- Level 1-5, Usual Activities- Level 1-5, Pain/Discomfort- Level 1-5, Anxiety/Depression- Level 1-5. The digits for the five dimensions will be combined into a 5-digit number that describes the patient's health state.
Diet choices
Measured using the Prime Diet Quality Score. The PDQS measures intake of the 22 component foods/food groups over the last 30 days with seven possible responses for each component ranging from "once a month or less" to "≥ 2 times/day." Scores are then summed to create a PDQS total diet quality score with a possible score from 0 to 126 with higher scores indicating a healthier diet.
Record sleeping habits
Pittsburgh Sleep Quality Index Component 1: Subjective sleep quality-question 9 Component 2: Sleep latency-questions 2 and 5a Component 3: Sleep duration-question 4 Component 4: Sleep efficiency-questions 1, 3, and 4 Component 5: Sleep disturbance-questions 5b-5j Component 6: Use of sleep medication-question 6 Component 7: Daytime dysfunction-questions 7 and 8 Global PSQI Score: Sum of seven component scores

Full Information

First Posted
April 20, 2023
Last Updated
May 24, 2023
Sponsor
Aberystwyth University
Collaborators
Phytoquest Ltd, Gateway Health Alliances, Inc, Welsh Government
search

1. Study Identification

Unique Protocol Identification Number
NCT05878847
Brief Title
Oral Supplement in Older Adults to Support Physical Fitness and Mental Well-being
Acronym
PQQA
Official Title
Oral Supplement in Older Adults to Support Physical Fitness and Mental Well-being
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 22, 2023 (Actual)
Primary Completion Date
December 22, 2023 (Anticipated)
Study Completion Date
December 22, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Aberystwyth University
Collaborators
Phytoquest Ltd, Gateway Health Alliances, Inc, Welsh Government

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Cucumbers have been anecdotally claimed to have anti-inflammatory activity for a long time, but the active principle was not identified. idoBR1 is an iminosugar amino acid isolated from fruits of certain cucumbers, Cucumis sativus (Cucurbitaceae), which has been shown to have anti-inflammatory activity. IminoTech Inc in the USA has produced a quality-controlled cucumber extract containing measured idoBR1 (Q-actin™) that has given good results in osteo-arthritis from oral use. The investigators are aiming to recruit a cohort (n = 50) of middle aged and older adults (>50 years) who will be randomised into Q-actin (2 x 10 mg gummies daily) or placebo (2 x 10 mg gummies daily) supplementation for 12 weeks. Using hand grip strength and the Nine-Hole Peg Test (9HPT) the investigators will measure physical strength and finger dexterity respectively. The investigators will measure generic quality of life with the EuroQol 5 Dimension 5 (EQ-5D) questionnaire, sleep quality, diet choices and collect urine samples for the investigation into the chemical composition (metabolomics). Randomisation will be blinded, and the participant and the researcher will not know what group participants in until after the completion of the study, then it will be disclosed.
Detailed Description
Cucumbers have been anecdotally claimed to have anti-inflammatory activity for a long time, but the active principle was not identified. idoBR1 is an iminosugar amino acid isolated from fruits of certain cucumbers, Cucumis sativus (Cucurbitaceae), which has been shown to have anti-inflammatory activity. The investigators would like to explore if consumption of cucumber extract Q-actin when compared with placebo can have an impact on physical strength (measured by hand grip strength), finger dexterity (measured by Nine-Hole Peg Test (9HPT)) as well as quality of life (EuroQol 5 Dimension 5: EQ-5D questionnaire), sleep quality (Pittsburgh Sleep Quality Index), and diet (diet questionnaires are tailored to the participants eating habits, e.g., carnivore, vegetarian, fish, vegan etc). The investigators will explore urine chemical composition use high resolution metabolomics do this by looking at the chemical composition of home-collected urine. After pre-induction over the phone, if the person is eligible and still interested, the investigators will firstly run through an induction session. This can be done by phone, Teams or in person, whatever suits best. The study is split into three experimental sessions where the participant will be randomised to one of two supplements, Q-actin (2 x 10 mg gummies daily) or placebo (2 x 10 mg gummies daily) supplementation for 12 weeks. The vegan gummies will need to be consumed in the evening, before bed-time. Randomisation will be blinded, and the participant and the researcher will not know what group they in until after the completion of the study. The participant will need to come to the centre for physical strength and finger dexterity measurements using hand grip strength and the Nine-Hole Peg Test (9HPT) respectively. The investigators will measure generic quality of life with the EQ-5D questionnaire, record diet choices, record sleeping habits using the Pittsburgh Sleep Quality Index, and collect urine samples before and after the supplementation period. The investigators would like participants to restrict from consumption of cucumber, gherkins, and melon for two days before coming to the centre. Whilst undergoing the study, if necessary, the research team will be easily contacted by email, Teams and phone. The visits Tea, coffee and biscuits will be provided at each visit. Each visit will take up to an hour Induction First, the participant will be welcomed with tea or coffee. The investigators will run through how the investigators are working safely during coronavirus (COVID-19). Then the investigators will introduce the participant to the urine sampling boxes, provide crib sheets and email the participant with a link to a video demonstration, if needed. The investigators will run through the logistics of study visits and the tasks that will be completed. The investigators will also email the participant a link to the EQ-5D questionnaire, Pittsburgh Sleep Quality Index, and diet questionnaire, or give them a paper copy, so that they can complete these in the centre or at home (whatever is preferred). The investigators will arrange the participants testing day 1, 2 and 3 visit dates and times. Testing day 1 (start) On the participants pre-organised day and time, will will ask them to collect 2 x 4ml first urine sample at home using home-collection urine kits. These samples will be stored in the participants home home fridge between 2-5 degrees. The participant will then come to the centre at a pre-organised timeslot with their urine samples for physical strength and finger dexterity activities. Will will ask them to make sure they complete their EQ-5D, Pittsburgh Sleep Quality Index, and diet questionnaire before they start their supplementation. Testing day 2 (after 6 weeks) After the 6-week supplementation period the investigators would like the participant to complete the activities that they undertook during testing day 1. On their pre-organised day and time, will will ask them to collect 2 x 4ml first urine sample at home using home-collection urine kits. The investigators will ask the participant to store these samples in their home fridge between 2-5 degrees. The participant will then come to the centre for their pre-organised timeslot with their urine samples for physical strength and finger dexterity activities. The investigators will ask the participant to make sure they complete their EQ-5D, Pittsburgh Sleep Quality index, and diet questionnaire before or just after testing day 2. Testing day 3 (after 12 weeks) After the 12-week supplementation period the investigators would like the participant to complete the activities that they undertook during testing day 1. On their pre-organised day and time, will will ask them to collect 2 x 4ml first urine sample at home using home-collection urine kits. The investigators will ask the participant to store these samples in their home fridge between 2-5 degrees. The participant will then come to the centre for their pre-organised timeslot with their urine samples for physical strength and finger dexterity activities. The investigators will ask the participant to make sure they complete their EQ-5D, Pittsburgh Sleep Quality index, and diet questionnaire before or just after testing day 3. There will also be an optional feedback questionnaire at the end.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteo-arthritis
Keywords
Older adults, Mental well-being, Physical fitness, Sleep quality

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Model Description
The study is split into three experimental sessions where you will be randomised to one of two supplements, Q-actin (2 x 10 mg gummies daily) or placebo (2 x 10 mg gummies daily) supplementation for 12 weeks
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Triple blinded
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Q-actin
Arm Type
Experimental
Arm Description
Q-actin gummies (2 x 10mg) daily for 12 weeks
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo gummies (2 x 10mg) daily for 12 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Q-actin
Other Intervention Name(s)
idoBR1
Intervention Description
idoBR1 is an iminosugar amino acid isolated from fruits of certain cucumbers, Cucumis sativus (Cucurbitaceae), which has been shown to have anti-inflammatory activity. IminoTech Inc in the USA has produced a quality-controlled cucumber extract containing measured idoBR1 (Q-actin™) that has given good results in osteo-arthritis from oral use.
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Placebo
Primary Outcome Measure Information:
Title
Physical strength
Description
Hand grip strength using a hand held dynamometer
Time Frame
Change from Baseline grip strength at 12 weeks
Title
Finger dexterity measurements
Description
Nine-Hole Peg Test (9HPT)
Time Frame
Change from baseline Finger dexterity at 12 weeks
Secondary Outcome Measure Information:
Title
EuroQol 5 Dimension 5L (combined score)
Description
EuroQol 5 Dimension 5 5L questionnaire: Generic quality of life. Mobility- Level 1-5 Self-Care- Level 1-5, Usual Activities- Level 1-5, Pain/Discomfort- Level 1-5, Anxiety/Depression- Level 1-5. The digits for the five dimensions will be combined into a 5-digit number that describes the patient's health state.
Time Frame
Reduced score from baseline EuroQol 5 Dimension 5 score at 12 weeks.
Title
Diet choices
Description
Measured using the Prime Diet Quality Score. The PDQS measures intake of the 22 component foods/food groups over the last 30 days with seven possible responses for each component ranging from "once a month or less" to "≥ 2 times/day." Scores are then summed to create a PDQS total diet quality score with a possible score from 0 to 126 with higher scores indicating a healthier diet.
Time Frame
Increased score from baseline Prime Diet Quality Score at 12 weeks
Title
Record sleeping habits
Description
Pittsburgh Sleep Quality Index Component 1: Subjective sleep quality-question 9 Component 2: Sleep latency-questions 2 and 5a Component 3: Sleep duration-question 4 Component 4: Sleep efficiency-questions 1, 3, and 4 Component 5: Sleep disturbance-questions 5b-5j Component 6: Use of sleep medication-question 6 Component 7: Daytime dysfunction-questions 7 and 8 Global PSQI Score: Sum of seven component scores
Time Frame
Decreased score from baseline Pittsburgh Sleep Quality Index at 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: over 50 years, mixed gender, mixed ethnicity Consenting adults >50 y Age Commit to urine sampling Able to commit to attending WARU or the remote centre for measurements of physical strength, finger dexterity, quality of life, diet choices, sleep Able to restrict from consumption of cucumber, gherkins, and melon for two days before coming to WARU or the remote centre Exclusion Criteria: Showing (or anyone within the household) any COVID-19 symptoms (see COVID-19 basic health screen)* Higher risk or vulnerable from coronavirus or live with someone at a higher risk of a severe illness from COVID-19 (over 70, undergoing cancer treatment, high risk of getting infections). Had a letter from the NHS advising you to shield (isolate) Had been at risk of exposure to COVID-19 such as travel, contact with someone with COVID-19, been exposed to the virus, or has been asked to self-isolate by the track and trace system. Serious health conditions that require daily long-term medication
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Amanda J Lloyd, PhD, BSc
Phone
07811618109
Email
abl@aber.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Alina Warren, Ms, BSc
Phone
07539440811
Email
arw21@aber.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amanda Jane J Lloyd, PhD, BSc
Organizational Affiliation
Aberystwyth University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Well-being and Health Assessment Research Unit (WARU)
City
Aberystwyth
State/Province
Ceredigion
ZIP/Postal Code
SY23 3FD
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amanda J Lloyd, PhD, BSc
Phone
07811618109
Email
abl@aber.ac.uk
First Name & Middle Initial & Last Name & Degree
Alina Warren, Ms, BSc
Phone
07539440811
Email
arw21@aber.ac.uk
First Name & Middle Initial & Last Name & Degree
Amanda J Lloyd, PhD, BSc
First Name & Middle Initial & Last Name & Degree
Alina Warren, Ms, BSc

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
individual participant data (IPD) will not be made available to other researchers.

Learn more about this trial

Oral Supplement in Older Adults to Support Physical Fitness and Mental Well-being

We'll reach out to this number within 24 hrs